Please ensure Javascript is enabled for purposes of website accessibility

Why Canada Goose Holdings, Catabasis Pharmaceuticals, and Globalstar Jumped Today

By Dan Caplinger - Dec 31, 2018 at 4:31PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out what made these stocks stand out on the final day of the year.

2018 ended on a quiet note Monday, as stock market benchmarks posted modest advances on the last day of the year. Overall, 2018 was disappointing for most investors, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all finishing well below where they started the year. Yet some individual stocks managed to post nice gains to try to build momentum going into 2019, and Canada Goose Holdings (GOOS -0.96%), Catabasis Pharmaceuticals (CATB -0.33%), and Globalstar (GSAT 0.00%) were among the top performers. Here's why they did so well.

Canada Goose celebrates its Chinese debut

Shares of Canada Goose Holdings rose almost 5% after the outerwear apparel company saw strong interest in its first retail store location in China. The Beijing-based store has pulled in large numbers of shoppers despite frigid weather conditions, and the retailer hopes that it'll mark the beginning of a much deeper relationship between the company and Chinese consumers. Many Canadian companies haven't been able to escape the prevailing tension in trade relations between China and the West, but the popularity of Canada Goose's fashions has been enough to overcome any ambivalence shoppers might have about buying from the store.

Five people on an icefield wearing heavy coats.

Image source: Canada Goose.

Catabasis tries to heal its stock

Catabasis Pharmaceuticals stock picked up 7% as investors responded to the company's latest capital-strategy move. Last week, the clinical-stage biopharmaceutical specialist said that it would do a reverse stock split, trading one new share of stock for every 10 old shares that shareholders owned. The reverse split was effective late Friday, with split-adjusted trading of the new shares starting in today's trading. Reverse splits typically follow poor stock performance and often only delay the inevitable, but Catabasis hopes that it'll be able to beat the odds and become one of the rare stocks to recover after making similar moves.

Globalstar flies higher

Finally, Globalstar shares soared 23.5%. The satellite communications specialist has responded extremely well following what many saw as a troubling stock offering earlier in December, at which Globalstar sold more than 171 million shares of stock for just $0.35 per share. That raised just $59 million for the company, but it was only dilutive to the extent that existing shareholders chose not to participate in the secondary offering. Now, investors seem more optimistic that Globalstar is in a better position to manage its balance sheet and keep its debt under control as it seeks to grow.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Globalstar Stock Quote
$1.31 (0.00%) $0.00
Catabasis Pharmaceuticals, Inc. Stock Quote
Catabasis Pharmaceuticals, Inc.
$3.01 (-0.33%) $0.01
Canada Goose Stock Quote
Canada Goose
$19.66 (-0.96%) $0.19

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.